Yüklüyor......
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
Although parenteral therapy with glycoprotein (GP) IIb/IIIa inhibitors has resulted in a reduced risk of death or myocardial infarction in patients with acute coronary syndromes and in patients undergoing percutaneous coronary intervention, the benefit is achieved only during the infusion period. Or...
Kaydedildi:
| Yayımlandı: | Clin Cardiol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley Periodicals, Inc.
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654967/ https://ncbi.nlm.nih.gov/pubmed/11129681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960231105 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|